TY - JOUR
T1 - Regulator of G protein signaling-4 controls fatty acid and glucose homeostasis
AU - Iankova, Irena
AU - Chavey, Carine
AU - Clapé, Cyrielle
AU - Colomer, Claude
AU - Guérineau, Nathalie C.
AU - Grillet, Nicolas
AU - Brunet, Jean François
AU - Annicotte, Jean Sébastien
AU - Fajas, Lluis
PY - 2008/11
Y1 - 2008/11
N2 - Circulating free fatty acids are a reflection of the balance between lipogenesis and lipolysis that takes place mainly in adipose tissue. We found that mice deficient for regulator of G protein signaling (RGS)-4 have increased circulating catecholamines, and increased free fatty acids. Consequently, RGS4-/- mice have increased concentration of circulating free fatty acids; abnormally accumulate fatty acids in liver, resulting in liver steatosis; and show a higher degree of glucose intolerance and decreased insulin secretion in pancreas. We show in this study that RGS4 controls adipose tissue lipolysis through regulation of the secretion of catecholamines by adrenal glands. RGS4 controls the balance between adipose tissue lipolysis and lipogenesis, secondary to its role in the regulation of catecholamine secretion by adrenal glands. RGS4 therefore could be a good target for the treatment of metabolic diseases.
AB - Circulating free fatty acids are a reflection of the balance between lipogenesis and lipolysis that takes place mainly in adipose tissue. We found that mice deficient for regulator of G protein signaling (RGS)-4 have increased circulating catecholamines, and increased free fatty acids. Consequently, RGS4-/- mice have increased concentration of circulating free fatty acids; abnormally accumulate fatty acids in liver, resulting in liver steatosis; and show a higher degree of glucose intolerance and decreased insulin secretion in pancreas. We show in this study that RGS4 controls adipose tissue lipolysis through regulation of the secretion of catecholamines by adrenal glands. RGS4 controls the balance between adipose tissue lipolysis and lipogenesis, secondary to its role in the regulation of catecholamine secretion by adrenal glands. RGS4 therefore could be a good target for the treatment of metabolic diseases.
UR - http://www.scopus.com/inward/record.url?scp=54349128871&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=54349128871&partnerID=8YFLogxK
U2 - 10.1210/en.2008-0717
DO - 10.1210/en.2008-0717
M3 - Article
C2 - 18635652
AN - SCOPUS:54349128871
SN - 0013-7227
VL - 149
SP - 5706
EP - 5712
JO - Endocrinology
JF - Endocrinology
IS - 11
ER -